The trading price of Esperion Therapeutics Inc. (NASDAQ:ESPR) closed lower on Monday, March 11, closing at $2.12, -3.20% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $5.18 and a 52-week low of $0.70. Over the past month, the stock has lost -17.83% in value.
Esperion Therapeutics Inc., whose market valuation is $361.29 million at the time of this writing, is expected to release its quarterly earnings report May 07, 2024 – May 13, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0.01 per share this quarter, however they have predicted annual earnings per share of -$0.44 for 2024 and $0.2 for 2025. It means analysts are expecting annual earnings per share growth of 78.30% this year and 145.50% next year.
Analysts have forecast the company to bring in revenue of $76.86 million for the current quarter, with the likely lows of $28.9 million and highs of $141.69 million. The average estimate suggests sales will likely up by 215.90% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $257.54 million. The company’s revenue is forecast to grow by 121.40% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Esperion Therapeutics Inc. No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest ESPR has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that ESPR’s price is currently -17.09% off the SMA20 and -15.41% off the SMA50. The RSI metric on the 14-day chart is currently showing 36.99, and weekly volatility stands at 7.40%. When measured over the past 30 days, the indicator reaches 9.04%. Esperion Therapeutics Inc. (NASDAQ:ESPR)’s beta value is currently sitting at 0.83, while the Average True Range indicator is currently displaying 0.23.
To see how Esperion Therapeutics Inc. stock has been performing in comparison to its peers in the industry, here are the numbers: ESPR stock’s performance was -3.20% in the latest trading, and -56.02% in the past year.
An evaluation of the daily trading volume of Esperion Therapeutics Inc. (NASDAQ:ESPR) indicates that the 3-month average is 6.38 million. However, this figure has increased over the past 10 days to an average of 4.41 million.
Currently, records show that 170.42 million of the company’s shares remain outstanding. The insiders hold 0.53% of outstanding shares, whereas institutions hold 48.10%. The stats also highlight that short interest as of Feb 15, 2024, stood at 18.57 million shares, resulting in a short ratio of 2.92 at that time. From this, we can conclude that short interest is 10.03% of the company’s total outstanding shares. It is noteworthy that short shares in February were down slightly from the previous month’s figure, which was 20.2 million. However, since the stock’s price has seen -29.10% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
